National Lupus Outreach and Clinical Trial Education Program
About
This notice solicits applications for projects to implement integrated, community-based models that increase participation of underrepresented populations in lupus clinical trials across the full participation pathway, including awareness, referral, screening, enrollment and retention.
The National Lupus Outreach and Clinical Trial Education Program funds projects designed to increase participation of underrepresented populations in lupus clinical trials. This grant supports organizations and institutions implementing integrated, community-based models that address barriers across the entire clinical trial participation pathway—from initial awareness and education through referral, screening, enrollment, and long-term retention. This program is ideal for nonprofits, research institutions, community health organizations, and healthcare providers committed to improving diversity in lupus research and expanding access to cutting-edge treatments. By addressing health disparities in clinical trial participation, grant recipients help advance lupus treatment innovation while building trust and engagement within underrepresented communities. If your organization is working to eliminate barriers to clinical trial participation or strengthen community outreach in lupus care, this grant can provide the resources needed to implement scalable, evidence-based programs. Awards support comprehensive initiatives that combine patient education, community partnerships, and clinical coordination to meaningfully increase trial enrollment among populations historically underrepresented in research.
Funding Facts
● Applications openDeadline
July 10, 2026
Award Amount
Up to $500K
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Grant Amount
Up to $500K
Deadline
2026-07-10
Grant Type
federal
Application Cycle
Annual (Deadline: July 10, 2026)
Best For
Nonprofits, research institutions, academic medical centers, community health organizations, and clinical trial sites focused on increasing diversity in lupus clinical research
Frequently Asked Questions
Who is eligible for National Lupus Outreach and Clinical Trial Education Program?
Specific eligibility criteria are not listed in the available program information. Typically, this type of program may be open to nonprofits, research institutions, academic medical centers, community health organizations, and clinical trial sites. For detailed eligibility requirements, application restrictions, and institutional qualifications, contact the sponsoring agency directly or visit the official program website.
How much funding does National Lupus Outreach and Clinical Trial Education Program provide?
Funding amounts range up to $500,000 per project. The specific award amount may vary depending on project scope, organizational capacity, and program priorities. Check the official program announcement for information about typical grant sizes and how funding tiers are determined.
How do I apply for National Lupus Outreach and Clinical Trial Education Program?
Applications are submitted through the sponsoring federal agency's grants portal. The application typically requires a detailed project narrative describing your community-based model, target populations, specific strategies to increase clinical trial awareness and enrollment, organizational qualifications, budget, and evaluation plan. Review the full program solicitation on the official website for specific submission requirements, required documents, and any pre-application meetings or letters of intent.
What can National Lupus Outreach and Clinical Trial Education Program funding be used for?
Funding supports development and implementation of integrated, community-based projects that increase underrepresented populations' participation in lupus clinical trials. This includes activities related to patient awareness campaigns, clinical trial education, community outreach partnerships, referral coordination, screening support, enrollment facilitation, and retention programs. Projects should address barriers to participation and demonstrate how they will sustain improvements across the full clinical trial pathway.
Last updated: July 5, 2026